PENG Block vs. Intraoperative Local Anesthetic Infiltration for Total Hip Arthroplasty

Launched by LONDON HEALTH SCIENCES CENTRE RESEARCH INSTITUTE OR LAWSON RESEARCH INSTITUTE OF ST. JOSEPH'S · Jun 2, 2023

Keywords

ClinConnect Summary

This clinical trial is looking at two different methods for managing pain after total hip replacement surgery (known as total hip arthroplasty or THA). Currently, the standard approach involves using a mix of local anesthetic, morphine, and ketorolac for pain relief during the surgery. However, some patients may not be able to use opioids or certain pain medications. In this study, researchers want to see if a new technique called the PENG block, which numbs specific nerves in the hip area, can provide similar pain relief without the need for those medications. They are also interested in whether this new method can save patients money.

To be eligible for this trial, participants need to be adults over 18 years old and scheduled for a specific type of hip surgery called a direct lateral approach. They should be able to give consent to join the study. However, there are some exclusions, such as patients with certain medical conditions or those who have had previous surgeries on the hip. If you decide to participate, you can expect close monitoring and care throughout the process, as the study aims to ensure your safety and comfort while exploring this new pain management option.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Adult patient (\>18 years old)
• • 2. Undergoing THA with a direct lateral surgical approach (transgluteal approach)
• • 3. Ability to provide verbal/written consent to participate in this trial
• Exclusion Criteria:
• • 1. Patient with any contraindication for spinal anesthesia
• • 2. Patient with any contraindication for regional analgesia
• • 3. Patient undergoing THA with a direct anterior surgical approach
• • 4. Patients undergoing THA for hip revision
• • 5. Patients undergoing THA under One Day Stay (ODS) admission
• • 6. Patients that received opioids intrathecally
• • 7. Patients having residual motor block six hours after the completion of the spinal anesthesia.
• • 8. Patients with a history of regular opioid intake for more than three months
• • 9. Patients incapable of performing knee extension of the same operative side
• • 10. Pregnant patients